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Hearing loss due to mutations in the connexin gene family, which encodes gap junctional
proteins, is a common form of hereditary deafness. In particular, connexin 26 (Cx26,
GJB2) mutations are responsible for ~50% of non-syndromic hearing loss, which is the
highest incidence of genetic disease. In the clinic, Cx26 mutations cause various auditory
phenotypes ranging from profound congenital deafness at birth to mild, progressive hearing
loss in late childhood. Recent experiments demonstrate that congenital deafness mainly
results from cochlear developmental disorders rather than hair cell degeneration and
endocochlear potential reduction, while late-onset hearing loss results from reduction of
active cochlear amplification, even though cochlear hair cells have no connexin expression.
However, there is no apparent, demonstrable relationship between specific changes
in connexin (channel) functions and the phenotypes of mutation-induced hearing loss.
Moreover, new experiments further demonstrate that the hypothesized K+-recycling
disruption is not a principal deafness mechanism for connexin deficiency induced hearing
loss. Cx30 (GJB6), Cx29 (GJC3), Cx31 (GJB3), and Cx43 (GJA1) mutations can also
cause hearing loss with distinct pathological changes in the cochlea. These new studies
provide invaluable information about deafness mechanisms underlying connexin mutation-induced hearing loss and also provide important information for developing new
protective and therapeutic strategies for this common deafness. However, the detailed
cellular mechanisms underlying these pathological changes remain unclear. Also, little is
known about specific mutation-induced pathological changes in vivo and little information
is available for humans. Such further studies are urgently required.
Keywords: gap junction, non-syndromic hearing loss, cochlear supporting cell, hair cell, cochlear development,
active cochlear amplification, potassium recycling, inner ear

Introduction
Gap junctions are intercellular channels that connect the cytoplasm of adjacent cells, providing a
direct intracellular conduit for intercellular communication. A gap junctional channel is formed by
two hemichannels; each hemichannel is composed of six subunits (Bennett et al., 1991; Harris, 2001).
Gap junctions exist in both vertebrates and invertebrates. The gap junction proteins in vertebrates
are mainly encoded by the connexin gene family, which consists of more than 20 connexin isoforms
(Willecke et al., 2002), whereas the gap junction proteins in invertebrates are encoded by the unrelated
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innexin family. Pannexin is an innexin homologous gene and also
encodes gap junctional proteins in vertebrates (Bruzzone et al.,
2003a; Baranova et al., 2004). However, unlike connexins, pannexins usually form non-junctional membrane channels on the
cell surface to provide an intracellular–extracellular conduit and
are considered unable to form integral gap junctional channels
between cells (Boassa et al., 2007; Penuela et al., 2007; Sosinsky
et al., 2011).
Unlike typical ion channels (such as K+, Na+, and Ca++ channels), gap junction channels possess a relatively large pore size
(~10–15 Å) and can allow passage of ions, cell signaling molecules,
and small molecules up to ~1.5 kDa (Bennett et al., 1991; Harris,
2001). This direct intercellular communication pathway plays an
important role in embryonic and postembryonic development,
cancer suppression, and many physiological and pathological
functions. Connexin mutations can cause severe deafness and are
responsible for most cases (> 50%) of hereditary hearing loss in the
clinic (Kelsell et al., 1997; Zelante et al., 1997; Denoyelle et al., 1998;
Estivill et al., 1998; Kelley et al., 1998), indicating that connexin
gap junctions play a critical role in hearing. Connexin mutations,
mutation-induced auditory phenotypes, and gap junctional function in the cochlea have been extensively summarized by previous
reviews [e.g., Zhao et al. (2006), Castillo and Castillo (2011), and
Chan and Chang (2014)]. In this review, we mainly focus on the
pathogenesis and deafness mechanisms underlying this common
hereditary deafness.

of pathogenic changes caused by these deafness mutations. (i)
Most mutants cannot correctly track to the cell surface to form
functional gap junction channels (Martin et al., 1999; Choung
et al., 2002; D’Andrea et al., 2002; Thonnissen et al., 2002; Bruzzone
et al., 2003b; Wang et al., 2003; Bicego et al., 2006). (ii) Mutants
can also have dominant or trans-dominant negative effects on
wild-type (WT) Cx26 and co-expressed Cx30 (Thomas et al.,
2004; Bicego et al., 2006; Deng et al., 2006; Palmada et al., 2006;
de Zwart-Storm et al., 2008; Yum et al., 2010; Zhang et al., 2011).
(iii) Some mutants (e.g., p.M34T) can be correctly synthesized
and target to the plasma membrane, but cannot form efficient
intercellular gap junction channels (Skerrett et al., 2004; Bicego
et al., 2006). (iv) Some mutants retain permeability to ions but
not to small molecules. For example, the Cx26 p.V84L mutant is
permeable to ions but is impermeable to IP3 (Beltramello et al.,
2005; Zhang et al., 2005). (v) Some deafness-associated mutants,
such as p.V84L and p.V95M, can form functional homotypic gap
junction channels but cannot form functional heterotypic channels
(Choung et al., 2002; Thonnissen et al., 2002; Bruzzone et al., 2003b;
Wang et al., 2003), indicating that these mutants may specifically
impair heterogeneous channels in vivo. A gap junction is formed
by two hemichannels. Hemichannels can also solely function on
the cell surface to provide an intracellular–extracellular conduit.
Connexin hemichannels are usually closed at normal extracellular
Ca++ level under normal physiological conditions but could be
opened under some pathological conditions (Bennett et al., 2003;
Goodenough and Paul, 2003). (vi) Some mutants, e.g., p.G45E, can
cause abnormal hemichannel activity and opening at the normal
extracellular Ca++ level leading to cell lysis and death (Stong et al.,
2006; Gerido et al., 2007). (vii) Finally, it has been reported that the
Cx26 p.R75W mutant can impair gap junctional plaque formation
and reduce the area of gap junctional plaque and protein levels. The
reduction is associated with excessive endocytosis with increased
expression of caveolin 1 and 2 (Kamiya et al., 2014). However,
except for a few mutations, there is no apparent, demonstrable relationship between mutation phenotypes and auditory phenotypes.
There is also no definite relationship between mutation-induced
specific changes in connexin (channel) functions and phenotypes
of mutation-induced deafness. This lack of correspondence suggests that mutation-induced hearing loss is not directly determined
by the mutation-induced pathogenic changes in channel function.
Other factors, such as compensation and cooperation of other
co-expressed connexins and in vivo functional impairment, may
also play important roles in hearing loss.

Phenotypes of Cx26 (GJB2)
Mutation-Induced Hearing Loss
Connexin 26 (Cx26, GJB2) mutations are a common genetic cause
for non-syndromic hearing loss and are responsible for ~50% of
non-syndromic hearing loss in children (Rabionet et al., 2000).
Non-syndromic deafness can be autosomal dominant deafness
(DFNA, DFN: deafness; A: dominant), autosomal recessive
deafness (DFNB, B: recessive), or X-linked deafness (DFNX,
X: X-linked). Each type is numbered in the order in which it was
described. The majority of Cx26 mutations are recessive (DFNB1)
but a few are dominant (DFNA3). In the clinic, various symptoms
and auditory phenotypes are observed. Cx26 mutations can result
in a mild-moderate to profound sensorineural hearing loss (Zhao
et al., 2006; Castillo and Castillo, 2011; Chan and Chang, 2014).
The mutation-induced hearing loss is not always congenital and
can be late-onset and progressive, starting or occurring in childhood (Orzan and Murgia, 2007; Pollak et al., 2007; Gopalarao et al.,
2008; Chan and Chang, 2014). This diversity of clinical appearances
implies that hearing loss induced by Cx26 mutations has various
pathological changes and different underlying deafness mechanisms.

Connexin Expression and Function
in the Cochlea
Connexin expression and gap junctional function in the inner
ear have been extensively summarized by previous reviews [e.g.,
Zhao et al. (2006)]. Here, we briefly summarize main findings and
information relevant to this review.

Functional Analyses of Cx26 Deafness
Mutations
To date, more than 100 GJB2 mutations have been identified to
be associated with deafness [connexins and deafness Web site:
http://davinci.crg.es/deafness/index.php, and also see Mani et al.
(2009), Castillo and Castillo (2011), and Chan and Chang (2014)].
Functional analyses in transfected cells in vitro reveal a variety
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In the cochlea, gap junctions exist extensively in the supporting
cells in the organ of Corti, the stria vascularis (SV), the spiral
ligament, the spiral limbus, and other cochlear non-sensory cells
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and structures (Kikuchi et al., 1995; Forge et al., 2003; Zhao and Yu,
2006; Liu and Zhao, 2008) (Figure 1). Two independent gap junctional networks have been identified in the inner ear: the epithelial
gap junctional network between supporting cells in the auditory
sensory epithelium in the organ of Corti and the connective tissue
gap junctional network between the connective tissue cells in the
cochlear lateral wall (Kikuchi et al., 1995). However, there is no
connexin expression in hair cells (Kikuchi et al., 1995; Zhao and
Santos-Sacchi, 1999; Zhao and Yu, 2006) or gap junctional coupling
between outer hair cells (OHCs) and supporting cells (Yu and
Zhao, 2009) (Figure 1).
Multiple connexin genes, GJB2 (Cx26), GJB6 (Cx30), GJB3
(Cx31), GJC3 (Cx29), and GJA1 (Cx43), have been identified
in the cochlea (Figure 1). Cx26 and Cx30 are the predominant
isoforms and are widely expressed in the epithelial and connective
tissues in a cell-specific and spatiotemporally complex fashion
(Kikuchi et al., 1995; Lautermann et al., 1998; Forge et al., 2003;
Zhao and Yu, 2006; Liu and Zhao, 2008). They are largely colocalized and can form homotypic and heterotypic/heteromeric
gap junction channels between native cochlear supporting cells
with asymmetrical-rectified gating, which allows one-directional
passage (Zhao, 2000; Zhao and Santos-Sacchi, 2000).
Compared to the extensive expression of Cx26 and Cx30, the
expression of other connexins in the cochlea is limited (Figure 1).
Cx31 has been detected in type III fibrocytes in the spiral ligament
in the cochlear lateral wall (Xia et al., 2000; López-Bigas et al., 2002;
Forge et al., 2003). Cx29 in the cochlea is expressed on the Schwann
cells wrapping the spiral ganglion (SG) neurons (Yang et al., 2005;

Eiberger et al., 2006; Tang et al., 2006). Using immunofluorescent
staining, Cx43 (GJA1) was initially reported on bone of the otic
capsule and on cells lining the inside of the bony wall in adult
animals (Forge et al., 2003; Suzuki et al., 2003). However, using
lacZ reporter gene in Cx43 KO mice, it was found that Cx43 was
highly expressed in the connective tissues and weakly expressed in
the immature sensory epithelium of the cochlea from embryonic
day 15.5 to the first week after birth and was almost exclusively
expressed in the bone of the otic capsule after P8 (Cohen-Salmon
et al., 2004).

Gap Junctional Function in the Cochlea

The hypothetical functions of gap junctions in the cochlea include
K+-recycling (Santos-Sacchi and Dallos, 1983; Santos-Sacchi, 1987,
1991; Kikuchi et al., 1995; Spicer and Schulte, 1998; Zhao and
Santos-Sacchi, 1998; Zhao, 2000) (Figure 1), nutrient and energy
supply (Zhao, 2005; Zhao et al., 2005), intercellular signaling
(Beltramello et al., 2005; Zhang et al., 2005; Zhao et al., 2005;
Gossman and Zhao, 2008), endocochlear potential (EP) generation (Teubner et al., 2003; Chen et al., 2014), generation and
maintenance of the unique electrochemical environments of the
endolymph and perilymph (Cohen-Salmon et al., 2002; Teubner
et al., 2003; Chen et al., 2014), and participation in active cochlear
amplification (Yu and Zhao, 2009; Zhu et al., 2013, 2015). Recently,
it has been reported that gap junction-mediated intercellular communication also plays an important role in epithelial repair in the
cochlea (Forge et al., 2013; Jagger et al., 2014). Thus, dysfunction of

Figure 1 | Connexin expression and hypothesized K+-recycling in the
cochlea. Cx26 and Cx30 co-localized in supporting cells of the organ of Corti,
the spiral limbus (SLM), the stria vascularis (SV), and fibrocytes of the spiral
ligament (SPL). Cx31 is localized at type II and IV fibrocytes in the subcentral
region (SR) below the spiral prominence (SP). Cx43 is expressed in the bone of
the otic capsule. Cx29 is localized only at the Schwann cells wrapping the

Frontiers in Cellular Neuroscience | www.frontiersin.org

spiral ganglion neurons in the auditory canal. However, hair cells have no
connexin expression. Inset: the organ of Corti. CT, cochlear tunnel; DC, Deiters
cell; HC, Hensen cell; IHC, inner hair cell; IPC, inner pillar cell; OHCs, outer hair
cells; OPC, outer pillar cell; TM, tectorial membrane; I–V, type I–V fibrocytes.
Modified from Forge et al. (2003), Cohen-Salmon et al. (2004), Zhao and Yu
(2006), and Liu and Zhao (2008).
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gap junctions or connexin mutations can influence many aspects
of cochlear function. For more detailed information, see Sections
“Pathological Changes in the Cochlea in Cx26 Deficient Mice,”
“Deafness Mechanisms Underlying Cx26 Deficiency Induced
Hearing Loss,” and “Hearing Loss and Pathological Changes
Induced by Mutations of Other Connexins.”

function in the cochlea, even though Cx31 mutations can also
induce hearing loss (Liu et al., 2000; Oh et al., 2013; and also
see Section “Hearing Loss and Pathological Changes Induced by
Mutations of Other Connexins”).

Pathological Changes in the Cochlea in
Cx26 Deficient Mice

Hemichannel Function in the Cochlea

Cx26 and Cx30 are expressed in the cochlea and in the brain.
However, cochlear implants can restore hearing function in
connexin mutation-induced hearing loss (Rayess et al., 2015),
indicating major pathological changes in the cochlea.

Gap junction hemichannels can also function on the cell surface to provide an intracellular–extracellular conduit. Because
hemichannels possess a relatively large pore size, they can
release small molecules, such as ATP, which can subsequently
activate purinergic P2 receptors to form an extracellular pathway
for intercellular signaling. Gap junction hemichannels in the
cochlear sensory epithelium can release ATP and IP3 and thus
participate in intercellular signaling, control of OHC electromotility, K+-sinking, and gap junctional coupling (Zhao et al., 2005;
Gossman and Zhao, 2008; Yu and Zhao, 2008; Zhu and Zhao,
2010, 2012). It has been reported that some deafness-associated
mutants lose permeability to small biochemical molecules, thus
impairing intercellular signaling (Beltramello et al., 2005; Zhang
et al., 2005), or cause abnormal hemichannel activity eventually
leading to cell lysis and death (Stong et al., 2006; Gerido et al.,
2007). This indicates that gap junctional channels and connexin
hemichannels may play an important role in cell signaling in
the cochlea.
However, we recently found that Cx26 knockout or Cx30
knockout had little effect on ATP release in the cochlea under
normal physiological conditions, while Panx1 deletion can abolish
ATP release in the cochlea (Chen et al., 2015). These data suggest
that pannexin channels rather than connexin hemichannels in
the cochlea play an important role under normal physiological
conditions.

Pathological Changes in the Cochlea in
Cx26 Knockout Mice

Based on observations in Cx26 deletion mice, pathological
changes of Cx26 deficiency in the cochlea include (i) cochlear
developmental disorders, (ii) hair cell and SG neuron degeneration, (iii) EP reduction, and (iv) impairment in active cochlear
amplification (Cohen-Salmon et al., 2002; Sun et al., 2009; Wang
et al., 2009; Liang et al., 2012; Zhu et al., 2013, 2015; Chen et al.,
2014).
Cochlear Developmental Disorders in Cx26
Deficient Mice
In mice, the cochlea shows normal morphology and the cochlear
tunnel starts to open at postnatal day 5 (P5). By P10, the EP and K+
concentration in the endolymph rise to high levels (Ehret, 1976;
Kraus and Aulbach-Kraus, 1981). Hearing starts around P14 and
matures at P19–20 (Liang et al., 2012) (Figure 2). Cx26-null mice
are embryonic lethal due to deficiency of transplacental uptake of
glucose (Gabriel et al., 1998). Using conditional knockout techniques, it has been found that deletion of Cx26 in the cochlea at
the embryonic period or P0–1 can cause cochlear developmental
disorders (Wang et al., 2009; Liang et al., 2012; Chen et al., 2014).
The tectorial membrane attaches at the inner sulcus cells and the
under-tectorial-membrane space is lost; the cochlear tunnel is
also filled (Figure 3A). Recently, we further found that deletion
of Cx26 expression in the cochlea before P5 can induce cochlear
developmental disorders with congenital deafness (Chen et al.,
2014). However, with deletion of Cx26 after P5, cochlear development proceeded normally, the cochlear tunnel opened normally,
and hearing remained normal at young ages (Chen et al., 2014)
(Figures 3 and 4). These data suggest that Cx26 expression in the
cochlea at the early postnatal development stage (<P5) is critical
for cochlear postnatal development and maturation.

Connexin-Specific Function in the Cochlea

Cx26 and Cx30 are predominant connexin isoforms in the cochlea
(Forge et al., 2003; Zhao and Yu, 2006; Liu and Zhao, 2008). It
has been found that inner ear gap junctions have strong charge
selectivity; Cx26 is associated with anionic permeability in the
cochlea (Zhao, 2005). This result is consistent with previous reports
that Cx26 channels are permeable to both anionic and cationic
molecules (Elfgang et al., 1995; Manthey et al., 2001; Beltramello
et al., 2003), while Cx30 channels are impermeable to anionic
molecules (Manthey et al., 2001; Beltramello et al., 2003). Thus,
Cx26 in the cochlea is mainly responsible for permeability to
anions and may play an important role in intercellular signaling,
given that most cell signaling molecules (e.g., IP3, ATP, cAMP, and
cGMP) are anions. This may be a reason why Cx26 but not Cx30
mutations induce high-incidence of hearing loss and why Cx30
knockin cannot restore hearing of Cx26 deficient mice (see Section
“Hearing Restoration in Connexin Deficient Mice”).
However, functions of other connexins in the cochlea remain
largely unclear. Cx29 is expressed on the Schwann cells at the
auditory nerve and Cx43 is expressed in the bone. They may be
involved in SG neuron activation and bone formation. Cx31 is
mainly expressed in the type III fibrocytes in the cochlear lateral
wall (Forge et al., 2003). Currently, little is known about Cx31
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Cochlear Cell Degeneration in Cx26 Deficient Mice
Cx26 deletion in the cochlea can cause hair cell and SG neuron
degeneration (Sun et al., 2009; Liang et al., 2012), even though
hair cells have neither connexin expression (Kikuchi, et al., 1995;
Zhao and Yu, 2006) nor gap junctional coupling (Zhao and SantosSacchi, 1999; Yu and Zhao, 2009). It has been reported that cell
degeneration is detectable around P14 (Sun et al., 2009; Wang et al.,
2009). However, substantial hair cell loss is not visible until adulthood. Severe cochlear hair cell loss and SG neuron degeneration
also only occurred in middle and basal turns, i.e., in middle and
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Figure 3 | Cochlear developmental disorders and hearing loss
induced by deletion of Cx26 in the cochlea at different postnatal
times. (A) Cochlear development after deletion of Cx26 at P1 and P10.
White arrows indicate that the cochlear tunnel is filled when Cx26 was
deleted at P1 but developed normally when Cx26 was deleted at P10. Empty
triangles indicate lack of the under-tectorial-membrane space; the tectorial
membrane is attached to the inner sulcus cells following deletion of Cx26 at
P1. (B) Hearing loss following deletion of Cx26 at different postnatal times.
The ABR thresholds were measured at P30 and were normalized to that in
WT mice. Corresponding to cochlear developmental disorders, deletion of
Cx26 before P5 can induce severe hearing loss. However, hearing remains
normal in young mice following deletion of Cx26 after P6. Modified from
Chen et al. (2014).

Figure 2 | Cochlear postnatal development and functional
maturation in mice. (A) Postnatal development of the cochlea. Arrows
indicate that the cochlear tunnel starts to open at postnatal day 5 (P5) and
fully opens at P10. (B) Postnatal developments of endocochlear potential
(EP) and [K+]. Modified from Hibino et al. (2004). (C) Hearing maturation in
mice. ABR thresholds dramatically drop at P11–16 and reach normal levels
around P20. Modified from Liang et al. (2012).

high frequency regions (Sun et al., 2009; Wang et al., 2009; Liang
et al., 2012). In addition, functional analyses show that hair cells
in Cx26 deficient mice developed normally and retained normal
function (Liang et al., 2012). So far, the mechanism underlying hair
cell and SG neuron degeneration in Cx26 deficient mice remains
unclear and needs to be further studied.

have ATP-dependent Kir4.1 K+ channels, this will generate a 110–
120 mV transmembrane potential (Nernst’s K+ equilibrium
potential) between the intracellular space and the intrastrial
space, i.e., +115–125 mV in the intrastrial space with respect
to normal extracellular space. Finally, this positive intrastrial
potential eventually leads to positive EP (+100–120 mV) in
the endolymph in the scala media (Chen and Zhao, 2014;
Chen et al., 2015).
Gap junctional coupling is required for positive EP generation. Deletion of Cx26 expression in the cochlea can cause EP
reduction (Cohen-Salmon et al., 2002; Chen et al., 2014; Zhu
et al., 2015). In comparison with that of WT mice, EP in Cx26
KO mice was reduced by ~50% (Cohen-Salmon et al., 2002;
Chen et al., 2014). However, EP remained normal following
targeted-deletion of Cx26 expression in Deiters supporting
cells and outer pillar supporting cells (Zhu et al., 2013), which
are located around OHCs in the cochlear sensory epithelium
(Figure 1). This indicates that impairment of the cochlear
sensory gap junction network may have little effect on EP
generation in the inner ear (Zhu et al., 2013; Chen and Zhao,
2014; Chen et al., 2015).

EP Reduction in Cx26 Deficient Mice
Endocochlear potential is a positive voltage (+100–120 mV) in
the cochlear endolymph in the scala media (Figure 1) and is a
driving force for propelling K+ ions through transduction channels
in hair cells and producing auditory receptor current and potential.
Positive EP is required for normal hearing and is generated in the
cochlear lateral wall by a complex process (Chen and Zhao, 2014;
Chen et al., 2015). Based on a “two-cell” model, EP generation
is initiated at fibrocyte cells in the spiral ligament, where Na+/
K+-ATPases and Na+, K+, 2Cl- cotransporters depolarize cells to
approximately -5 mV. Then, the intermediate cells in the SV are
consequently depolarized to approximately -5 mV through gap
junctional coupling, which is formed by Cx26 and Cx30 (Liu and
Zhao, 2008). Since the apical membrane of the intermediate cells
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mechanism(s) underlying connexin mutation-induced syndromic and non-syndromic hearing loss may be similar.

Reduction of Active Cochlear Amplification in
Cx26 Deficient Mice
Normal hearing relies on active cochlear amplification to
increase hearing sensitivity and frequency selectivity (Dallos,
2008; Hudspeth, 2008). Two forms of active cochlear mechanics
have been proposed: one is prestin-based OHC electromotility;
another is stereocilium-based hair bundle movement. OHC
electromotility serves as a major source of active cochlear amplification in mammals (Brownell et al., 1985; Zheng et al., 2000;
Ashmore, 2008). We found that Cx26 deficiency in the cochlear
supporting cells can affect OHC electromotility (Yu and Zhao,
2009; Zhu et al., 2013, 2015), even though OHCs lack connexin
expression and gap junctional coupling (Kikuchi, et al., 1995;
Zhao and Santos-Sacchi, 1999; Zhao and Yu, 2006; Yu and Zhao,
2009). OHCs in Cx26 deficient mice still retain normal development and electromotility (Liang et al., 2012; Zhu et al., 2013,
2015). However, OHC electromotility was shifted (Zhu et al.,
2013, 2015) and active cochlear amplification as measured by
distortion product otoacoustic emission (DPOAE) was reduced
(Zhu et al., 2013, 2015). Currently, detailed mechanisms for how
connexin deficiency in the cochlear supporting cells influences
OHC electromotility and eventually reduces active cochlear
amplification remain unclear. This needs to be further examined
in future studies.

Deafness Mechanisms Underlying Cx26
Deficiency Induced Hearing Loss
Deletion of Cx26 in the cochlea can cause cochlear developmental
disorders, severe hair cell loss, SG neuron degeneration, and EP
reduction (Cohen-Salmon et al., 2002; Kudo et al., 2003; Sun
et al., 2009; Wang et al., 2009; Liang et al., 2012; Chen et al.,
2014). These findings provide invaluable information about
pathological changes induced by Cx26 deficiency. However, the
underlying deafness mechanism(s) is still unclear. Several deafness
mechanisms, such as K+-recycling and Ca++-wave propagation
hypotheses, have been proposed (Kelsell et al., 1997; Beltramello
et al., 2005; Zhao et al., 2006). However, Cx26 mutations can cause
various hearing loss phenotypes ranging from congenital deafness
to late-onset, progressive hearing loss. Apparently, they have different underlying deafness mechanisms (Liang et al., 2012; Zhu
et al., 2013, 2015; Chen et al., 2014).

Hypothesized Deafness Mechanism for Cx26
Deficiency Induced Hearing Loss
Hypothesized K+-Recycling Impairment: Not a Principal
Deafness Mechanism
During acoustic stimulation, K+ ions in the endolymph in the
scala media flow into hair cells through the mechano-transduction
channels to generate auditory receptor current and potential. Then,
K+ ions are pumped out to the extracellular space in the perilymph
through the hair cell’s lateral wall to restore hair cell function. The
expelled K+ ions are subsequently sunken by cochlear supporting cells and are eventually transported back to the endolymph
in the scala media via gap junctional pathways (Figure 1). This
hypothesized function of gap junctional coupling in the inner ear
was proposed about 30 years ago (Santos-Sacchi and Dallos, 1983;
Kikuchi et al., 1995). Later, it was further hypothesized that Cx26
mutations may impair gap junctional coupling and disrupt such
K+-recycling leading to K+ accumulation in the extracellular space
near hair cells, thereby eventually damaging hair cells and causing hearing loss (Kelsell et al., 1997; Zhao et al., 2006). However,
this hypothesized deafness mechanism lacks direct experimental
evidence, even though it has been widely referred to. As mentioned
above, not all Cx26 deafness mutations disrupt permeability of
gap junction channels to ions; some deafness mutants can retain
permeability to ions. Moreover, Cx26 mutations can cause various phenotypes of hearing loss (Castillo and Castillo, 2011; Chan
and Chang, 2014), indicating that there are different underlying
deafness mechanisms. Most importantly, our recent study demonstrates that mice with deletion of Cx26 in the cochlea after birth
can retain normal hearing at young ages (Chen et al., 2014; Zhu
et al., 2015) (Figure 4). These new data indicate that K+-recycling
may not be important for hearing, if Cx26 deficiency disrupts the
K+-recycling. Or, alternatively, the K+-recycling is important for
hearing but not impaired by Cx26 deletion due to compensation
by co-expressed Cx30. In any case, the hypothesized K+-recycling
disruption cannot be a principal deafness mechanism for Cx26
deficiency induced hearing loss (Zhu et al., 2015).

Hearing Loss and Pathological Changes in
the Cochlea in Cx26 Deafness Mutation
Knockin Mice

Currently, more than 100 Cx26 deafness mutations have been
identified. However, only two Cx26 mutation knockin mouse
models have been established. One is Cx26 p.R75W mutation
knockin mouse line (Kudo et al., 2003), and another is Cx26 p.S17F
knockin mouse line (Schütz et al., 2011).
Cx26 p.R75W knockin mice are viable. Similar to Cx26 knockout mice, Cx26 p.R75W transgenic mice displayed congenital
deafness and cochlear developmental disorders, including filling
of the cochlear tunnel (Kudo et al., 2003). Cell degeneration is also
visible (Kudo et al., 2003; Inoshita et al., 2008). However, OHCs
developed normally and retained normal function, but DPOAE
was reduced (Inoshita et al., 2008; Minekawa et al., 2009).
For Cx26 p.S17F transgenic mice, homozygous mice are not
viable, whereas the surviving heterozygous mice show a moderate
hearing loss. The auditory brainstem response (ABR) threshold
was increased by ~35 dB sound pressure level (SPL) in these mice,
and EP was reduced by 20–40% (Schütz et al., 2011).
It should be noted that both p.R75W and p.S17F mutations
are dominant mutations and cause syndromic hearing loss
(Richard et al., 1998, 2002). Functional analyses showed that
p.R75W mutation can target to the plasma membrane forming
gap junctional plaques between cells, but has no channels function (Chen et al., 2005; Zhang et al., 2011; Kamiya et al., 2014),
while p.S17F mutation cannot target to the plasma membrane
forming functional gap junction channels or hemichannels
(Richard et al., 2002; Lee et al., 2009a). These data further
demonstrate that mutation-induced pathological changes in
connexin (channel) function are not directly linked to the final
auditory phenotypes. These data also suggest that deafness
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hearing loss (Beltramello et al., 2005). However, it is currently
unclear how such Ca++-wave propagation in the cochlea is related
to hearing function and deafness, or whether it physiologically
occurs in the cochlea. Moreover, it is unclear whether other deafness mutations can impair such Ca++-wave propagation, since
some mutants can still form functional gap junctional channels
permeable to ions (see above). Finally, similar to the K+-recycling
disruption hypothesis, our recent finding that after deletion of
Cx26 in the cochlea mice can still retain normal hearing at young
ages (Chen et al., 2014; Zhu et al., 2015) (Figure 4) indicates that
Ca++-wave propagation impairment cannot be a principal deafness
mechanism for Cx26 deficiency induced hearing loss.

Deafness Mechanisms Underlying Cx26
Deficiency Induced Congenital Deafness

As mentioned above, mouse models show that deletion of Cx26 at
birth can cause congenital deafness with cochlear developmental
disorders, hair cell degeneration, and EP reduction (Wang et al.,
2009; Liang et al., 2012; Chen et al., 2014).
Cell degeneration is Not a Primary Cause for Cx26
Deficiency Induced Congenital Deafness
In mice, hearing starts at P14 and matures at P19–20. We (Liang
et al., 2012) found that hearing in Cx26 KO mice is completely
absent throughout the whole postnatal developmental period. The
threshold of ABR, which is an auditory evoked potential in the
brain recorded via electrodes placed on the scalp, was even greater
than 110 dB SPL, indicating complete hearing loss. However,
substantial hair cell loss was not visible until adulthood, although
it has been reported that cell degeneration is detectable at young
ages (Sun et al., 2009; Wang et al., 2009). Moreover, substantial cell
degeneration was only visible at the middle and basal turns, i.e., in
middle and high frequency regions (Sun et al., 2009; Wang et al.,
2009; Liang et al., 2012). However, congenital, complete hearing
loss occurred throughout the whole frequency range (Liang et al.,
2012). Thus, hair cell loss is not a primary cause for Cx26 deficiency
induced congenital deafness.

Figure 4 | Normal hearing in young Cx26 KO mice after deletion of
Cx26 after birth. (A,B) Immunofluorescent staining for Cx26 in the cochlea
in WT and Cx26 KO mice at P30 following deletion of Cx26 at P10. No
positive labeling is visible in the Cx26 KO mouse. (C) ABR thresholds of WT
and Cx26 KO mice were measured at P30 and P90 following deletion of
Cx26 at P10. A green arrow indicates that the ABR threshold in Cx26 KO
mice at P30 remained normal, even though the expression of Cx26 in the
cochlea was already deleted [see (B)]. At P90, Cx26 KO mice had a
significant increase in ABR threshold, displaying hearing loss. **, P < 0.001,
t-test. Scale bars: 50 μm. Modified from Zhu et al. (2015).

Congenital Deafness is Not Caused by EP Reduction
Endocochlear potential is also reduced in Cx26 KO mice (CohenSalmon et al., 2002; Chen et al., 2014). However, EP reduction is
not associated with hearing loss in Cx26 KO mice. As mentioned
above, the ABR threshold in Cx26 KO mice was even greater than
110 dB SPL, demonstrating complete hearing loss (Liang et al.,
2012; Chen et al., 2014). However, the EP in Cx26 KO mice was
not completely abolished and had a large variability. In some cases,
the EP remained even at higher levels (>70 mV; Cohen-Salmon
et al., 2002; Chen et al., 2014).

Hypothesis of Impairment in Propagation of Ca++-Waves
in the Cochlear Sensory Epithelium
As intercellular channels, gap junctions also play an important role
in intercellular signaling and propagation of Ca++-waves among
cells. The spread of Ca++-waves among cells can be enacted by
the passage of Ca++ and IP3 between cells through gap junctions,
or by the passage of ATP and IP3 through hemichannels and the
subsequent activation of P2 purinergic receptors and IP3 receptors
(Harris, 2001; Gossman and Zhao, 2008). Because the Cx26 deafness mutant p.R75W can impair the spread of Ca++-waves among
cells (Beltramello et al., 2005; Yum et al., 2010; Zhang et al., 2011;
Kamiya et al., 2014), it has been hypothesized that Cx26 deficiency
may impair Ca++-wave propagation in the cochlea leading to
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Cochlear Developmental Disorders are Associated with
Congenital Deafness Generation
The congenital deafness in Cx26 KO mice, however, is associated
with cochlear developmental disorders (Liang et al., 2012; Chen
et al., 2014) (Figure 3). Deletion of Cx26 in the cochlea before P5
could cause cochlear developmental disorders, the cochlear tunnel
was filled, and mice had congenital deafness (Chen et al., 2014).
However, when Cx26 was deleted after P5, the cochlea displayed

7

May 2015 | Volume 9 | Article 202

Wingard and Zhao

Connexin mutations and deafness mechanisms

normal development, the cochlear tunnel was open as normal,
and there was no congenital deafness (Chen et al., 2014; Zhu
et al., 2015). These data suggest that congenital deafness induced
by Cx26 deficiency is likely to result from cochlear developmental
disorders (Figure 3). However, the detailed mechanisms for how
Cx26 deficiency induces cochlear developmental disorders remain
unclear.

frequency hearing loss (Grifa et al., 1999). Functional analysis
shows that the Cx30 p.T5M mutation can track to the plasma
membrane but defective channel activity was observed in dye
transfer assay (Common et al., 2002; Berger et al., 2014). The
mutation can also impair permeability to IP3 (Zhang et al.,
2005).
It has been found that Cx30 p.A40V and p.I248V can also
cause non-syndromic hearing loss (Yang et al., 2007; Oh et al.,
2013). Wang et al. (2011) reported that Cx30 p.A40V mutation
could not target to the plasma membrane and accumulated in
the Golgi body. The mutant also exerted a dominant negative
effect on both WT Cx30 and Cx26, which impaired gap junction
formation. However, a recent report (Oh et al., 2013) showed that
both p.A40V and p.I248V deafness mutations could target to the
plasma membrane to form gap junctional channels; they were
permeable to calcium ions, but reduced permeability to propidium
iodide dye.
Cx30T5M/T5M knockin mice exhibited a mild, but significant
increase in their hearing thresholds of about 15 dB at all frequencies (Schütz et al., 2010). Western blot analysis showed significantly
downregulated expression levels of Cx26 and Cx30. However, Cx26
and Cx30 retained normal distribution patterns. The cochlea and
EP also developed normally. Electrical coupling, probed by dual
patch-clamp recordings, was normal. However, transfer of the
fluorescent tracer calcein between cochlear non-sensory cells was
reduced (Schütz et al., 2010).
Cx30 knockout mice also show deafness with absence of EP
(Teubner et al., 2003; Chen et al., 2014). After P18, the cochlear
sensory epithelium starts to degenerate via cell apoptosis (Sun
et al., 2009). However, it has been found that Cx26 expression at
the protein level in this Cx30 KO mouse line also decreased to
30%. Interestingly, restoration of Cx26 expression in this Cx30
KO mouse line by knockin of an external Cx26 copy can rescue
its hearing (Ahmad et al., 2007). Recently, it has been reported
that a new Cx30 conditional KO mouse line, in which half of
Cx26 expression is preserved, displays normal hearing (Boulay
et al., 2013). These data imply that hearing loss in Cx30 KO mice
may result from the accompanied reduction in Cx26 expression.
Currently, it is still unclear whether sole Cx30 deletion can induce
hearing loss.

Deafness Mechanisms Underlying Cx26
Deficiency Induced Late-Onset Hearing Loss

Cx26 deficiency can also induce late-onset hearing loss. Using
an inducible gene knockout technique, we found that deletion
of Cx26 expression in the cochlea after P5 can induce late-onset,
progressive hearing loss (Chen et al., 2014; Zhu et al., 2015). Mice
retained normal hearing before P30. Then, hearing loss became
apparent and severe at high frequencies (Zhu et al., 2015). This
progression of hearing loss is similar to late-onset, progressive
hearing loss observed in DFNA3 and DFNB1 non-syndromic
deafness patients, who have normal hearing in early life, followed
by hearing loss starting in childhood (Orzan and Murgia, 2007;
Pollak et al., 2007; Gopalarao et al., 2008).
This Cx26 conditional KO mouse shows normal cochlear
development and has no substantial hair cell loss (Zhu et al., 2015).
EP was significantly reduced. However, the EP reduction was not
associated with progressive hearing loss (Zhu et al., 2015), indicating that the EP reduction is also not a determining factor in Cx26
deficiency induced late-onset hearing loss. However, consistent
with DPOAE reduction observed in patients (Engel-Yeger et al.,
2002, 2003; Santarelli et al., 2007), the mouse model demonstrated
a progressive DPOAE reduction, severe at high frequencies; functional analysis also showed that OHC electromotility was shifted
(Zhu et al., 2015). These data indicate that late-onset hearing
loss induced by Cx26 deficiency may result from impairment in
active cochlear amplification. However, the underlying cellular
mechanism remains undetermined.

Hearing Loss and Pathological Changes
Induced by Mutations of Other Connexins
In addition to GJB2 (Cx26), multiple connexin genes GJB6 (Cx30),
GJB3 (Cx31), GJC3 (Cx29), and GJA1 (Cx43), have been identified
in the cochlea. Mutations of these connexin genes can also cause
hearing loss, even if they are rare.

Cx31 Mutation-Induced Hearing Loss and
Pathological Changes

The Cx31 mutations can cause both recessive and dominant
non-syndromic hearing loss, characterized by late-onset moderate deafness affecting high frequencies (Liu et al., 2000; Oh et al.,
2013). Functional analyses showed that some deafness mutations
(e.g., p.V27M, p.V43M, and p.V84I) could target to the plasma
membrane to form gap junctional plaques but lost permeability
to dyes and ions (Oh et al., 2013). It has also been reported that
deafness mutation Cx31 p.V174M cannot target to the plasma
membrane and accumulated in the lysosomes in the mutanttransfected HeLa cells (Li et al., 2014). The mutant could also
impair Cx26 WT intracellular trafficking to the plasma membrane,
but did not influence trafficking of Cx31 WT (Li et al., 2014). Cx31
deficiency in mice causes transient placental dysmorphogenesis
but does not impair hearing (Plum et al., 2001).

Cx30 Mutation-Induced Hearing Loss and
Pathological Changes

Cx30 is a predominant connexin isoform, which is extensively
co-expressed with Cx26 in the cochlea (Forge et al., 2003;
Zhao and Yu, 2006; Liu and Zhao, 2008). Cx30 mutations can
also induce hearing loss. It has been reported that a 342-kb
deletion truncating the GJB6 (Cx30) gene is associated with
non-syndromic hearing loss through either homozygous deletion of Cx30 or digenic inheritance of a Cx30 deletion and a
Cx26 mutation (Castillo et al., 2002). It has also been reported
that the Cx30 missense mutation p.T5M at the N-terminus
is associated with autosomal dominant non-syndromic deafness (DFNA3), characterized by late-onset, middle to high
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Hearing Restoration in Connexin
Deficient Mice

Cx29 Mutation-Induced Hearing Loss and
Pathological Changes

Cx29 mutations can also cause non-syndromic hearing loss (Hong
et al., 2010a; Wang et al., 2010). Cx29 KO could result in delay
in maturation of hearing threshold, severe loss of myelination, a
prolongation in latency and distortion in the wave I of the ABR,
loss of high frequency sensitivity, and increased sensitivity to noise
damage (Tang et al., 2006). However, a study from another group
showed that deletion of Cx29 had no effect on hearing (Eiberger
et al., 2006). The reason for these conflicting results is currently
unclear.

It has been reported that restoration of Cx26 expression by
knockin of an external Cx26 copy in the Cx30 KO mouse line
can rescue its hearing, because the Cx26 expression level in the
Cx30 KO mice was also dramatically reduced (Ahmad et al., 2007).
However, Cx30 expression in Cx26 deficient mice was not reduced
(Zhu et al., 2015), and knockin of an external Cx30 copy in Cx26
deficient mice cannot rescue hearing (Qu et al., 2012). Unlike
Cx30 knockin, it has been found that knockin of Cx32 (GJB1)
in Cx26 deficient mice can restore hearing (Degen et al., 2011).
As mentioned above (Section “Connexin-Specific Function in
the Cochlea”), permeability of gap junctions and hemichannels
in the cochlea is highly charge dependent and Cx26 expression
is associated with anionic permeability in the cochlea (Zhao,
2005). Cx26 and Cx30 are predominant connexin isoforms in
the cochlea (Forge et al., 2003; Zhao and Yu, 2006; Liu and Zhao,
2008). However, Cx26 channels are permeable to both anionic
and cationic molecules (Elfgang et al., 1995; Manthey et al., 2001;
Beltramello et al., 2003), while Cx30 channels are impermeable
to anionic molecules (Manthey et al., 2001; Beltramello et al.,
2003). Thus, Cx26 is able to compensate for Cx30 function, while
Cx30 cannot completely compensate for Cx26 function. Cx32 is
similar to Cx26 in that it is permeable to both cationic and anionic
molecules (Elfgang et al., 1995). This may be a reason why Cx32
knockin but not Cx30 knockin can restore hearing function in
Cx26 deficient mice. However, the detailed mechanisms need to
be further clarified.
Recently, it has also been reported that a genetic approach to
restore Cx26 expression in the cochlea in Cx26 KO mice after birth
can preserve both hair cells and SG neurons but cannot restore
hearing function (Yu et al., 2014). This indicates that restoration
of hearing function is dependent on not only the level of gene
expression but also the timing of gene expression.

Cx43 Mutation-Induced Hearing Loss and
Pathological Changes

Cx43 (GJA1) mutations were also initially linked to nonsyndromic autosomal recessive deafness (Liu et al., 2001).
However, it is now clear that the mutations are located in
the GJA1 pseudogene rather than in GJA1 (Paznekas et al.,
2003; Hong et al., 2010b). Recently, a new study (Kim et al.,
2013) reported that immunofluorescent staining for Cx43
showed strong labeling in the mid-internal auditory canal in
the modiolus, which represents the transition zone between
Schwann cells and oligodendrocytes. Young Cx43 heterozygous
mice (3–4 months old) showed mild-moderate hearing loss
(Kim et al., 2013). The hearing loss became severe when the
mice were old.

Connexin Expression and Pathogenesis
in the Human Cochlea
Despite extensive studies of connexin expression in the animal
cochlea (Kikuchi et al., 1995; Forge et al., 2003; Zhao and Yu, 2006;
Liu and Zhao, 2008), little is known about connexin expression
in the human inner ear. It has been reported that Cx26 and Cx30
in the human cochlea have similar expression patterns to animals
(Liu et al., 2009). Recently, by use of the human fetal cochlea, it
has been found that the expression of Cx26 and Cx30 is detectable in the outer sulcus cells, but not in the spiral ligament in
the cochlear lateral wall at 18 weeks of gestation (Locher et al.,
2015). However, because of the very limited availability of samples,
connexin expression in the human cochlea still remains largely
undetermined.
Moreover, although there are numerous clinical reports of
connexin mutation-associated hearing loss, there is little description of the pathological changes in humans. Studies of human
temporal bone CT imaging showed that approximately 50% of
ears of subjects with GJB2 mutations have temporal bone anomaly
(Propst et al., 2006; Lee et al., 2009b). Few studies on the pathogenesis of Cx26 mutations have been done. So far, there is only
one case-report of a patient that had Cx26 p.G35delG mutation
and p.E101G missense mutation with profound hearing loss (Jun
et al., 2000). Microscopic observation revealed nearly complete
degeneration of hair cells and agenesis of the SV but no neural
degeneration. However, other factors, such as aging, cannot be
excluded as contributors to these pathological changes. Further
studies are needed to define the mutation-associated pathological
changes in the human cochlea.
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Summary and Prospection
Cx26 mutations are the major cause of hereditary deafness and can
induce congenital deafness and late-onset hearing loss (Castillo
and Castillo, 2011; Chan and Chang, 2014). Connexin-deletion
mouse models show that congenital deafness induced by Cx26
deficiency is associated with cochlear developmental disorders
rather than hair cell loss and EP reduction (Liang et al., 2012; Chen
et al., 2014), and that late-onset hearing loss induced by Cx26 deficiency results from the reduction of active cochlear amplification
(Zhu et al., 2013, 2015). The new data also demonstrate that the
hypothesized K+-recycling disruption is not a principal deafness
mechanism for Cx26 deficiency induced hearing loss (Chen et al.,
2014; Zhu et al., 2015). These new studies provide a full image of
deafness mechanisms for Cx26 mutation-induced hearing loss and
also provide important information for developing new protective
and therapeutic strategies for this common deafness.
However, the cellular mechanisms underlying Cx26 deficiency
induced cochlear developmental disorders remain unclear. The
mechanisms whereby Cx26 deficiency in the supporting cells influences OHC electromotility and active cochlear amplification are
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also unclear. Moreover, it is unknown whether specific mutations
of connexins will produce the same pathological changes as connexin knockout mice. Finally, little is known about pathological
changes in the human cochlea, and it is unclear whether the
observed pathological changes in mice are similar to humans.
Creation of specific connexin mutation knockin mouse models
and investigation of pathological changes in the human cochlea are
urgently required. The knockin transgenic mice can also provide
important information about the relationship between mutated

protein expression and absence of protein expression in vivo.
Recently, it has been reported that administration of vitamins A,
C, and E and magnesium ameliorated progressive hearing loss
in a child with Cx26 mutation (Thatcher et al., 2014). However,
the underlying mechanism(s) is not known. These new findings
further indicate that a more comprehensive understanding of this
common hereditary deafness is important and urgent and will have
a tremendous impact on many people, given connexin mutations
account for more than 50% of hereditary hearing loss.
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